Suvretta Capital Management, LLC Merck & Co., Inc. Transaction History

Suvretta Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $1.55 Million - $1.69 Million	15,500 New	15,500 $1.69 Million
Q4 2018 Feb 14, 2019	SELL	$65.24 - $75.71 $246 Million - $286 Million	-3,772,520 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $103 Million - $121 Million	1,786,393 Added 89.94%	3,772,520 $268 Million
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $101 Million - $119 Million	1,986,127 New	1,986,127 $121 Million

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Suvretta Capital Management, LLC with notifications on news.